Condition: Colorectal Neoplasms · Breast Neoplasms · Head and Neck Neoplasms · Sponsor: Rutgers, The State University of New Jersey
To prospectively evaluate the efficacy and safety of DPYD-guided dosing strategies in a real-world clinical setting, specifically by comparing the incidence of severe (Grade 3 and 4) fluoropyrimidine-related toxicities of heterozygous DPYD variant patients assigned to DPYD-guided reduced dosing versus patients with standard dosing in the control arm.
This description comes directly from the study's public registry record.
Howard S Hochster, MD · 732-253-5618 · howard.hochster@rutgers.edu
Christian F Misdary · 732-253-5618 · cm1344@cinj.rutgers.edu
Always discuss trial participation with your own doctor first.
| RWJBarnabas Health Clara Maas Medical Center | Belleville, New Jersey, United States | Recruiting |
| Trinitas Hospital and Comprehensive Cancer Center | Elizabeth, New Jersey, United States | Recruiting |
| RWJBarnabas Health - Robert Wood Johnson University Hospital, Hamilton | Hamilton, New Jersey, United States | Recruiting |
| RWJBarnabas Health Jersey City Medical Center | Jersey City, New Jersey, United States | Recruiting |
| Cooperman Barnabas Medical Center | Livingston, New Jersey, United States | Recruiting |
| Jack and Sheryl Morris Cancer Center | New Brunswick, New Jersey, United States | Recruiting |
| RWJBarnabas Health - Robert Wood Johnson University Hospita | New Brunswick, New Jersey, United States | Recruiting |
| Cancer Center Initiative | Newark, New Jersey, United States | Recruiting |
| University Hospital | Newark, New Jersey, United States | Recruiting |
| RWJBarnabas Health Newark Beth Israel Medical Center | Newark, New Jersey, United States | Recruiting |
| RWJBarnabas Health - Robert Wood Johnson University Hospital Somerset | Somerville, New Jersey, United States | Recruiting |
| RWJBarnabas Health - Community Medical Center | Toms River, New Jersey, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07158164